MedPath

PTeye in Parathyroid Adenoma

Recruiting
Conditions
Parathyroid Adenoma
Registration Number
NCT06913296
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

Identifying the parathyroids is compulsory for success of parathyroidectomy for parathyroid adenoma. Near-infrared autofluorescence devices have been proposed as useful intraoperative tools for the identification of parathyroid glands. The aim of the present study is to evaluate the correlation of PTeye autofluorescence device with biochemical data of parathyroid adenoma patients.

Detailed Description

Identifying the parathyroids is compulsory for success of parathyroidectomy for parathyroid adenoma. Near-infrared autofluorescence devices have been proposed as useful intraoperative tools for the identification of parathyroid glands. Two approaches are available to surgeons to perform near-infrared autofluorescence: (i) Camera-based systems (CBS) and (ii) Probe-based systems such as PTeyeâ„¢ (Medtronic, Minneapolis, MN).The aim of the present study is to evaluate the correlation of PTeye autofluorescence device with biochemical data of parathyroid adenoma patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age >18 years old
  • primary hyperparathyroidism caused by adenoma
  • patient's informed consent acquired
Exclusion Criteria
  • Secondary and tertiary hyperparathyroidism
  • Re-operation for adenoma
  • Previous neck surgery
  • Patient enrolled in another study that may affect the results of this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
assess the correlation of PTeye values with biochemical dataintraoperatively and 1st postoperative day

Biochemical data included are pre- and postoperative parathyroid hormone, serum calcium, phosphorus and vitamin D levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aristotle Univeristy of Thessaloniki

🇬🇷

Thessaloniki, Greece

© Copyright 2025. All Rights Reserved by MedPath